Home > Education Hub > DTx France 2022

DTx France 2022

July 5, 2022 | Paris, France

We are pleased to announce that we will be joining as speakers and exhibitors at DTx France 2022. This hybrid event will focus on the latest DTx trends, regulatory framework, market access, and much more.

Meet us there to learn how we at Alira Health are impacting the lives of patients with our digital health solutions and how we can help patients and physicians manage chronic conditions.

Events

Category:

Market Access Regulatory

Published on:

June 30, 2022

Our speaker

Romain Finas

VP, Real-World Evidence

Our delegates

Marc Nomaksteinsky

Marc Nomaksteinsky

Partner

Lamouri Bessalah

Lamouri Bessalah

Digital Health Solutions Director

Would you like to meet Alira Health at DTx France 2022 in Paris? Contact us to set up a meeting.

Contact us to set up a meeting

Related news

Webinars March 28, 2025

How Sustainability and Health Equity Are Reshaping Market Access Policy in Europe

This webinar will explore sustainability and health equity impact on reimbursement and procurement decisions in Europe and provide practical insights on how companies can adapt to the new landscape.

EU Market Access Sustainability

Articles March 6, 2025

ATMPs: Access, Pricing, and Ethical Issues in Perspective

Start reading this sneak peek of our recent analysis of access, pricing and ethical issues for advanced therapies medicinal products.

Advanced Therapies Market Access Orphan Drug Pricing

Articles February 24, 2025

New Regulation on Health Technology Assessment: Impact in France

Discover the new Regulation on Health Technology Assessment impacts on market access processes in France.

EU Healthcare Technology Regulatory

Articles February 17, 2025

Sustainable Pricing: An Opportunity to Improve Patient Access

Discover key pricing strategies to improve pharmaceutical health equity and price sustainability.

Market Access Pricing Sustainability

Articles January 24, 2025

How to Navigate the JCA Era: Market Access Strategy Optimization in the EU

With the JCA now in effect, we spoke with Andrea Mantovani, Alira Health Partner, Market Access and Pricing, about its impact on pharmaceutical companies hoping to bring new therapies to market.

EU Market Access

News January 8, 2025

Alira Health Launches the Global Payer Forum 2025 in Partnership with UPF Barcelona School of Management, NEWDIGS at Tufts Medical Center, and the University College of London

Alira Health is excited to announce the second year of the Global Payer Forum, a landmark educational initiative in partnership with distinguished academic institutions, UPF Barcelona(...)

Health Policy Market Access Pharma

Articles December 18, 2024

Market Access and Pricing Landscape for Diagnostic Radiopharmaceuticals

Discover the current market access and pricing landscape for diagnostic radiopharmaceuticals in key European markets, including the specific challenges, and discusses best practices(...)

Market Access Pricing Radiopharmaceuticals